MEI Historical Financial Ratios

MEIP Stock

USD 2.85 0.05 1.79%

MEI Pharma is lately reporting on over 104 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.69 will help investors to properly organize and evaluate MEI Pharma financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

About MEI Financial Ratios Analysis

MEI PharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MEI Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MEI financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MEI Pharma history.

MEI Pharma Financial Ratios Chart

At this time, MEI Pharma's Current Ratio is relatively stable compared to the past year. As of 02/01/2025, Receivables Turnover is likely to grow to 542.72, while Days Sales Outstanding is likely to drop 0.69.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing MEI Pharma stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MEI Pharma sales, a figure that is much harder to manipulate than other MEI Pharma multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is MEI Pharma dividend as a percentage of MEI Pharma stock price. MEI Pharma dividend yield is a measure of MEI Pharma stock productivity, which can be interpreted as interest rate earned on an MEI Pharma investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from MEI Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MEI Pharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.At this time, MEI Pharma's Current Ratio is relatively stable compared to the past year. As of 02/01/2025, Receivables Turnover is likely to grow to 542.72, while Days Sales Outstanding is likely to drop 0.69.

	2024	2025 (projected)
Dividend Yield	0.55	0.49
Price To Sales Ratio	0.33	0.32

Dividend Yield Price To Sales Ratio

MEI Pharma fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.15	0.78	0.32	0.9	0.29	-0.88	0.37	0.78	1.0	-0.88	-0.22	-0.89	-0.29	0.04	0.15	0.6	0.93	-0.47	0.31	0.15	-0.05	-0.47	-0.39	0.19	-0.16
Dividend Yield	0.15		0.28	0.47	0.18	0.72	-0.13	0.26	0.28	0.15	-0.13	-0.51	-0.19	-0.07	0.13	1.0	0.28	0.2	-0.05	0.42	1.0	-0.04	-0.05	0.04	0.72	-0.58
Ptb Ratio	0.78	0.28		0.17	0.71	0.51	-0.67	0.61	1.0	0.78	-0.67	-0.27	-0.71	-0.08	0.03	0.28	0.69	0.77	-0.44	0.08	0.28	-0.13	-0.43	-0.45	0.3	-0.31
Days Sales Outstanding	0.32	0.47	0.17		0.41	0.64	-0.34	-0.05	0.17	0.33	-0.34	-0.6	-0.38	-0.9	0.24	0.46	0.21	0.38	-0.15	0.88	0.47	-0.08	-0.15	0.34	0.66	-0.29
Book Value Per Share	0.9	0.18	0.71	0.41		0.3	-0.96	0.23	0.71	0.89	-0.96	-0.32	-0.97	-0.37	0.04	0.18	0.29	0.99	-0.42	0.46	0.18	0.04	-0.42	-0.08	0.23	-0.16
Free Cash Flow Yield	0.29	0.72	0.51	0.64	0.3		-0.16	0.49	0.51	0.3	-0.16	-0.49	-0.26	-0.41	0.29	0.72	0.52	0.33	-0.04	0.52	0.72	0.04	-0.03	-0.09	0.84	-0.55
Operating Cash Flow Per Share	-0.88	-0.13	-0.67	-0.34	-0.96	-0.16		-0.16	-0.67	-0.87	1.0	0.43	0.99	0.31	0.06	-0.13	-0.26	-0.96	0.48	-0.39	-0.13	0.07	0.48	0.06	-0.19	0.25
Capex To Depreciation	0.37	0.26	0.61	-0.05	0.23	0.49	-0.16		0.61	0.38	-0.16	-0.12	-0.25	0.1	0.05	0.26	0.73	0.31	0.04	-0.15	0.26	0.4	0.05	-0.51	0.11	-0.24
Pb Ratio	0.78	0.28	1.0	0.17	0.71	0.51	-0.67	0.61		0.78	-0.67	-0.27	-0.71	-0.08	0.03	0.28	0.69	0.77	-0.44	0.08	0.28	-0.13	-0.43	-0.45	0.3	-0.31
Ev To Sales	1.0	0.15	0.78	0.33	0.89	0.3	-0.87	0.38	0.78		-0.87	-0.22	-0.89	-0.3	0.04	0.15	0.6	0.92	-0.47	0.31	0.15	-0.05	-0.47	-0.39	0.19	-0.16
Free Cash Flow Per Share	-0.88	-0.13	-0.67	-0.34	-0.96	-0.16	1.0	-0.16	-0.67	-0.87		0.43	0.99	0.31	0.06	-0.13	-0.26	-0.96	0.48	-0.39	-0.13	0.07	0.48	0.06	-0.19	0.25
Roic	-0.22	-0.51	-0.27	-0.6	-0.32	-0.49	0.43	-0.12	-0.27	-0.22	0.43		0.47	0.43	0.18	-0.51	-0.2	-0.34	0.32	-0.5	-0.51	0.27	0.32	-0.34	-0.69	0.83
Net Income Per Share	-0.89	-0.19	-0.71	-0.38	-0.97	-0.26	0.99	-0.25	-0.71	-0.89	0.99	0.47		0.33	0.05	-0.19	-0.32	-0.98	0.46	-0.43	-0.19	0.02	0.46	0.07	-0.25	0.31
Days Of Inventory On Hand	-0.29	-0.07	-0.08	-0.9	-0.37	-0.41	0.31	0.1	-0.08	-0.3	0.31	0.43	0.33		-0.22	-0.07	-0.15	-0.32	0.12	-0.78	-0.07	-0.01	0.12	-0.32	-0.41	0.05
Payables Turnover	0.04	0.13	0.03	0.24	0.04	0.29	0.06	0.05	0.03	0.04	0.06	0.18	0.05	-0.22		0.13	0.0	0.03	0.75	0.25	0.13	0.46	0.75	-0.43	0.22	0.2
Average Inventory	0.15	1.0	0.28	0.46	0.18	0.72	-0.13	0.26	0.28	0.15	-0.13	-0.51	-0.19	-0.07	0.13		0.28	0.2	-0.05	0.41	1.0	-0.03	-0.05	0.04	0.72	-0.57
Capex To Revenue	0.6	0.28	0.69	0.21	0.29	0.52	-0.26	0.73	0.69	0.6	-0.26	-0.2	-0.32	-0.15	0.0	0.28		0.37	-0.33	-0.06	0.28	-0.13	-0.33	-0.62	0.29	-0.26
Cash Per Share	0.93	0.2	0.77	0.38	0.99	0.33	-0.96	0.31	0.77	0.92	-0.96	-0.34	-0.98	-0.32	0.03	0.2	0.37		-0.44	0.42	0.2	0.02	-0.43	-0.16	0.25	-0.22
Pocfratio	-0.47	-0.05	-0.44	-0.15	-0.42	-0.04	0.48	0.04	-0.44	-0.47	0.48	0.32	0.46	0.12	0.75	-0.05	-0.33	-0.44		-0.06	-0.05	0.71	1.0	-0.21	-0.1	0.28
Interest Coverage	0.31	0.42	0.08	0.88	0.46	0.52	-0.39	-0.15	0.08	0.31	-0.39	-0.5	-0.43	-0.78	0.25	0.41	-0.06	0.42	-0.06		0.42	0.06	-0.06	0.46	0.51	-0.28
Payout Ratio	0.15	1.0	0.28	0.47	0.18	0.72	-0.13	0.26	0.28	0.15	-0.13	-0.51	-0.19	-0.07	0.13	1.0	0.28	0.2	-0.05	0.42		-0.04	-0.05	0.04	0.73	-0.58
Capex To Operating Cash Flow	-0.05	-0.04	-0.13	-0.08	0.04	0.04	0.07	0.4	-0.13	-0.05	0.07	0.27	0.02	-0.01	0.46	-0.03	-0.13	0.02	0.71	0.06	-0.04		0.71	-0.18	-0.18	0.27
Pfcf Ratio	-0.47	-0.05	-0.43	-0.15	-0.42	-0.03	0.48	0.05	-0.43	-0.47	0.48	0.32	0.46	0.12	0.75	-0.05	-0.33	-0.43	1.0	-0.06	-0.05	0.71		-0.21	-0.1	0.27
Days Payables Outstanding	-0.39	0.04	-0.45	0.34	-0.08	-0.09	0.06	-0.51	-0.45	-0.39	0.06	-0.34	0.07	-0.32	-0.43	0.04	-0.62	-0.16	-0.21	0.46	0.04	-0.18	-0.21		0.04	-0.09
Income Quality	0.19	0.72	0.3	0.66	0.23	0.84	-0.19	0.11	0.3	0.19	-0.19	-0.69	-0.25	-0.41	0.22	0.72	0.29	0.25	-0.1	0.51	0.73	-0.18	-0.1	0.04		-0.74
Roe	-0.16	-0.58	-0.31	-0.29	-0.16	-0.55	0.25	-0.24	-0.31	-0.16	0.25	0.83	0.31	0.05	0.2	-0.57	-0.26	-0.22	0.28	-0.28	-0.58	0.27	0.27	-0.09	-0.74

Click cells to compare fundamentals

MEI Pharma Account Relationship Matchups

MEI Pharma fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	12.57	1.86	0.9	0.29	0.33	0.32
Ptb Ratio	7.76	1.45	1.78	0.58	0.66	0.63
Days Sales Outstanding	37.13	108.38	90.08	0.64	0.73	0.69
Book Value Per Share	7.35	8.43	3.7	4.96	5.7	5.41
Free Cash Flow Yield	(0.1)	(0.65)	(1.2)	(2.66)	(3.06)	(2.9)
Operating Cash Flow Per Share	(5.68)	(7.84)	(7.88)	(7.58)	(6.82)	(7.16)
Stock Based Compensation To Revenue	0.4	0.21	0.0735	0.0349	0.0401	0.0381
Capex To Depreciation	2.48	1.47	0.0907	0.0183	0.021	0.02
Pb Ratio	7.76	1.45	1.78	0.58	0.66	0.63
Ev To Sales	12.56	1.71	0.81	0.23	0.27	0.26
Free Cash Flow Per Share	(5.8)	(7.91)	(7.89)	(7.58)	(6.82)	(7.16)
Roic	(0.13)	(0.48)	(0.49)	0.44	0.4	0.42
Net Income Per Share	(7.34)	(8.75)	(4.78)	2.67	2.4	2.52
Payables Turnover	0.22	0.16	0.3	0.12	0.14	0.13
Sales General And Administrative To Revenue	0.96	0.75	0.68	0.36	0.41	0.39
Research And Ddevelopement To Revenue	2.72	2.1	1.07	0.25	0.29	0.28
Capex To Revenue	0.0277	0.0118	7.17E-4	1.07E-4	1.23E-4	1.17E-4
Cash Per Share	27.25	24.64	15.12	5.75	6.62	6.29
Pocfratio	(10.04)	(1.56)	(0.83)	(0.38)	(0.34)	(0.36)
Capex To Operating Cash Flow	(0.0221)	(0.009826)	(6.67E-4)	(1.39E-4)	(1.59E-4)	(1.67E-4)
Pfcf Ratio	(9.82)	(1.54)	(0.83)	(0.38)	(0.34)	(0.36)
Days Payables Outstanding	1.6K	2.3K	1.2K	3.0K	2.7K	2.9K
Roe	(1.0)	(1.04)	(1.29)	0.54	0.48	0.51
Ev To Operating Cash Flow	(10.03)	(1.43)	(0.76)	(0.3)	(0.27)	(0.29)
Pe Ratio	(7.77)	(1.39)	(1.38)	1.07	0.96	1.01
Ev To Free Cash Flow	(9.81)	(1.42)	(0.75)	(0.3)	(0.27)	(0.29)
Net Debt To E B I T D A	0.004074	0.0811	0.11	(0.14)	(0.16)	(0.15)
Current Ratio	5.44	6.84	5.29	4.88	5.61	9.9
Tangible Book Value Per Share	7.35	8.43	3.7	4.96	5.7	5.41
Receivables Turnover	9.83	3.37	4.05	574.31	516.88	542.72
Graham Number	34.83	40.74	19.94	17.25	19.84	18.84
Shareholders Equity Per Share	7.35	8.43	3.7	4.96	5.7	5.41
Capex Per Share	0.13	0.077	0.005255	0.001051	0.001208	0.001148
Graham Net Net	4.68	5.68	0.69	4.5	5.18	4.92

Pair Trading with MEI Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with MEI Stock

0.69

JNJ

Johnson Johnson

Pair Corr

Moving against MEI Stock

0.5	LFCR	Lifecore Biomedical	Pair Corr
0.44	ALTS	ALT5 Sigma Symbol Change	Pair Corr
0.38	BFRI	Biofrontera	Pair Corr

The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.

The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

MEI Historical Financial Ratios

About MEI Financial Ratios Analysis

MEI Pharma Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

MEI Pharma fundamentals Correlations

MEI Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEI Pharma fundamentals Accounts

Pair Trading with MEI Pharma

Moving together with MEI Stock

Moving against MEI Stock

Additional Tools for MEI Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Average Inventory	+ 1.0	Dividend Yield
Payout Ratio	+ 1.0	Dividend Yield
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Payout Ratio	+ 1.0	Average Inventory

Cash Per Share	- 0.98	Net Income Per Share
Net Income Per Share	- 0.97	Book Value Per Share
Cash Per Share	- 0.96	Free Cash Flow Per Share
Cash Per Share	- 0.96	Operating Cash Flow Per Share
Free Cash Flow Per Share	- 0.96	Book Value Per Share
Operating Cash Flow Per Share	- 0.96	Book Value Per Share